ChristopherEWalshMD

Oncology • New York, NY

Hematologic Oncology

Associate Professor, Medicine, Icahn School of Medicine

Join to view full profile

Dr. Walsh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Walsh's full profile

Already have an account?

Office
1190 5th Avenue
Guggenheim Pav Mt Sinai Hosp Ruttenberg Treatment Ctr
New York, NY 10029
Phone+1 212-241-6756

Fax+1 212-423-0522

Education & Training

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1988 - 1993
University of North Carolina HospitalsResidency, Internal Medicine, 1986 - 1988
Tulane University School of MedicineClass of 1986

Certifications & Licensure

NY State Medical License 2002 - 2025
FL State Medical License 2021 - 2023
MD State Medical License 1988 - 2015
NC State Medical License 1987 - 2003
LA State Medical License 1986 - 1986
American Board of Internal Medicine Internal Medicine

Clinical Trials

Open-Label Single Ascending Dose of Adeno-associated Virus Serotype 8 Factor IX Gene Therapy in Adults With Hemophilia B Start of enrollment: 2013 Feb 11
Active, not recruiting
Phase 1, Phase 2

Publications & Presentations

PubMed

142 citations
Recombinant long-acting glycoPEGylated factor IX in hemophilia B: a multinational randomized phase 3 trial.
Peter William Collins, Guy Young, Karin Knobe, Faraizah Abdul Karim, Pantep Angchaisuksiri
Blood. 2014-12-18
124 citations
Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing.
Hengjun Chao, S. Gary Mansfield, Robert C Bartel, Suja Hiriyanna, Lloyd G. Mitchell
Nature Medicine. 2003-08-01
95 citations
BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expression
Barbara A. Konkle, Christopher E. Walsh, Miguel A. Escobar, Neil C. Josephson, Guy Young
Blood. 2021-02-11

Press Mentions

Gene Therapy May Be Cure for Some with Rare Blood DisorderApril 19th, 2018

Grant Support

Prevention Of The Complications Of Hemophilia Thru Hemophilila Treatment CentersCenters For Disease Control And Prevention2006–2008
Genetics Of Human Epilepsy And Cognitive DisordersNational Center For Research Resources2004–2007
Gene Therapy For The HemophiliasNational Heart, Lung, And Blood Institute2002–2006
Gene Transfer Of Hematopoietic Stem CellsNational Heart, Lung, And Blood Institute2002–2004
Gene Therapy For The HemophiliasNational Heart, Lung, And Blood Institute2002
Gene Transfer Of Hematopoietic Stem CellsNational Heart, Lung, And Blood Institute2001–2002
Signal Transduction Pathways For Neuronal MigrationNational Institute Of Neurological Disorders And Stroke1999–2002
Gene Therapy Transfer Of Fanconi Anemia Group A GeneNational Center For Research Resources2000
Fanconi Anemia--Pathophysiology And TreatmentNational Cancer Institute1998–1999